IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series

References

• Zargaran D, Zoller F, Zargaran A, Weyrich T, Mosahebi A. Facial skin ageing: key concepts and overview of processes. Int J Cosmet Sci. 2022;44:414–420. doi:10.1111/ics.12779
   PubMed Web of Science ®Google Scholar
• Griffiths TW. Facial ageing: how do we measure up? Br J Dermatol. 2015;172:1182. doi:10.1111/bjd.13785
   PubMed Web of Science ®Google Scholar
• Rexbye H, Petersen I, Johansens M, Klitkou L, Jeune B, Christensen K. Influence of environmental factors on facial ageing. Age Ageing. 2006;35:110–115. doi:10.1093/ageing/afj031
   PubMed Web of Science ®Google Scholar
• Prager W, Nogueira Teixeira D, Leventhal PS. IncobotulinumtoxinA for aesthetic indications: a systematic review of prospective comparative trials. Dermatol Surg. 2017;43:959–966. doi:10.1097/DSS.0000000000001076
   PubMed Web of Science ®Google Scholar
• Camargo CP, Xia J, Costa CS, et al. Botulinum toxin type A for facial wrinkles. Cochrane Database Syst Rev. 2021;7:CD011301. doi:10.1002/14651858.CD011301.pub2
   PubMedGoogle Scholar
• Ianhez M, Peres G, Miot HA. Neutralizing antibodies to botulinum toxin type a are rare following aesthetic indications. Aesthet Surg J. 2021;41:NP1800–NP1801. doi:10.1093/asj/sjab289
   PubMed Web of Science ®Google Scholar
• de Sanctis Pecora C, Ventura Ferreira K, Amante Miot H. ONE21 technique for an individualized assessment and treatment of upper face wrinkles in five pairs of identical twins with IncobotulinumtoxinA. J Cosmet Dermatol. 2022;21:1940–1947. doi:10.1111/jocd.14879
   PubMed Web of Science ®Google Scholar
• Raveendran SS, Anthony DJ. Classification and morphological variation of the frontalis muscle and implications on the clinical practice. Aesthetic Plast Surg. 2021;45:164–170. doi:10.1007/s00266-020-01937-2
   PubMed Web of Science ®Google Scholar
• de Sanctis Pecora C. One21: a novel, customizable injection protocol for treatment of the forehead with IncobotulinumtoxinA. Clin Cosmet Investig Dermatol. 2020;13:127–136. doi:10.2147/CCID.S237519
   PubMed Web of Science ®Google Scholar
• Pavicic T, Prager W, Kloppel M, Ravichandran S, Galatoire O. IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study. Clin Cosmet Investig Dermatol. 2015;8:135–142. doi:10.2147/CCID.S74519
   PubMedGoogle Scholar
• Yutskovskaya Y, Gubanova E, Khrustaleva I, et al. IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations. Clin Cosmet Investig Dermatol. 2015;8:297–306. doi:10.2147/CCID.S72301
   PubMedGoogle Scholar
• Sundaram H, Huang PH, Hsu NJ, et al. Aesthetic applications of botulinum toxin a in asians: an international, multidisciplinary, pan-asian consensus. Plast Reconstr Surg Glob Open. 2016;4:e872. doi:10.1097/GOX.0000000000000507
   PubMedGoogle Scholar
• Barnish MS, Turner S. The value of pragmatic and observational studies in health care and public health. Pragmat Obs Res. 2017;8:49–55. doi:10.2147/POR.S137701
   PubMed Web of Science ®Google Scholar
• Stella E, Di Petrillo A. Standard evaluation of the patient: the Merz scale. In: Injections in Aesthetic Medicine. Springer; 2014:33–50.
   Google Scholar
• Bland JM, Altman DG. Statistics notes: bootstrap resampling methods. BMJ. 2015;350:h2622. doi:10.1136/bmj.h2622
   PubMedGoogle Scholar
• Hu M, Lachin JM. Application of robust estimating equations to the analysis of quantitative longitudinal data. Stat Med. 2001;20:3411–3428. doi:10.1002/sim.962
   PubMed Web of Science ®Google Scholar
• Miot HA. Analysis of ordinal data in clinical and experimental studies. J Vasc Bras. 2020;19:e20200185. doi:10.1590/1677-5449.200185
   PubMedGoogle Scholar
• Miot HA. Correlation analysis in clinical and experimental studies. J Vasc Bras. 2018;17:275–279. doi:10.1590/1677-5449.174118
   PubMedGoogle Scholar
• Katz MH. Multivariable Analysis: A Practical Guide for Clinicians and Public Health Researchers. Cambridge university press; 2011.
   Google Scholar
• Parpia S, Morris TP, Phillips MR, et al. Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis. Eye. 2022;36(11):2073–2074. doi:10.1038/s41433-022-02108-0
   PubMed Web of Science ®Google Scholar
• Miola AC, Miot HA. P-value and effect-size in clinical and experimental studies. J Vasc Bras. 2021;20:e20210038. doi:10.1590/1677-5449.210038
   PubMedGoogle Scholar
• Miot HA. Sample size in clinical and experimental studies. J Vasc Bras. 2011;10:275–278. doi:10.1590/S1677-54492011000400001
   Google Scholar
• de Sanctis Pecora C, Pinheiro MVB, Ventura Ferreira K, Jacobino de Barros Nunes G, Miot HA. The one21 technique: an individualized treatment for glabellar lines based on clinical and anatomical landmarks. Clin Cosmet Investig Dermatol. 2021;14:97–105. doi:10.2147/CCID.S281901
   PubMed Web of Science ®Google Scholar
• Jia Z, Lu H, Yang X, et al. Adverse events of botulinum toxin type a in facial rejuvenation: a systematic review and meta-analysis. Aesthetic Plast Surg. 2016;40:769–777. doi:10.1007/s00266-016-0682-1
   PubMed Web of Science ®Google Scholar
• Hexsel D, Cartier H, Heden P, et al. Efficacy, safety, and subject satisfaction after abobotulinumtoxina treatment of upper facial lines. Dermatol Surg. 2018;44:1555–1564. doi:10.1097/DSS.0000000000001679
   PubMed Web of Science ®Google Scholar
• Ferreira LM, Talarico Filho S, Costa RO, et al. Efficacy and tolerability of a new botulinum toxin type A for cosmetic treatment of dynamic facial wrinkles: a prospective, Phase III, multicenter study. Surg Cosm Dermatol. 2009;1:58–63.
   Google Scholar
• Monheit GD, Baumann L, Maas C, Rand R, Down R. Efficacy, safety, and subject satisfaction after abobotulinumtoxina treatment for moderate to severe glabellar lines. Dermatol Surg. 2020;46:61–69. doi:10.1097/DSS.0000000000002013
   PubMed Web of Science ®Google Scholar
• Glogau R, Kane M, Beddingfield F, et al. OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines. Dermatol Surg. 2012;38:1794–1803. doi:10.1111/j.1524-4725.2012.02582.x
   PubMed Web of Science ®Google Scholar
• Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840–849. doi:10.1067/mjd.2002.121356
   PubMed Web of Science ®Google Scholar
• de Sanctis Pecora C, Bussamara Pinheiro MV, Figueiredo V, Guerra R. Aesthetic ONE21 technique for injecting incobotulinumtoxina into the forehead: initial experience with 86 patients. J Drugs Dermatol. 2021;20:31–37. doi:10.36849/JDD.5617
   PubMed Web of Science ®Google Scholar
• Alexander C, Elliott C, Valentine J, et al. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study. Dev Med Child Neurol. 2018;60:1165–1171. doi:10.1111/dmcn.13988
   PubMed Web of Science ®Google Scholar
• Boswell RG, Sun W, Suzuki S, Kober H. Training in cognitive strategies reduces eating and improves food choice. Proc Natl Acad Sci U S A. 2018;115:E11238–E11247. doi:10.1073/pnas.1717092115
   PubMed Web of Science ®Google Scholar
• Slimani M, Bragazzi NL, Tod D, et al. Do cognitive training strategies improve motor and positive psychological skills development in soccer players? Insights from a systematic review. J Sports Sci. 2016;34:2338–2349. doi:10.1080/02640414.2016.1254809
   PubMed Web of Science ®Google Scholar